R. ÇAKMAK Et Al. , "COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs?," Turkish Journal of Diabetes and Obesity , vol.5, no.3, pp.279-284, 2021
ÇAKMAK, R. Et Al. 2021. COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs?. Turkish Journal of Diabetes and Obesity , vol.5, no.3 , 279-284.
ÇAKMAK, R., TELCİ ÇAKLILI, Ö., ÇELİK, A. M., MUTLU, Ü., Nasıfova, V., SARIBEYLİLER, G., ... Alibeyoğlu, A.(2021). COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs?. Turkish Journal of Diabetes and Obesity , vol.5, no.3, 279-284.
ÇAKMAK, RAMAZAN Et Al. "COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs?," Turkish Journal of Diabetes and Obesity , vol.5, no.3, 279-284, 2021
ÇAKMAK, RAMAZAN Et Al. "COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs?." Turkish Journal of Diabetes and Obesity , vol.5, no.3, pp.279-284, 2021
ÇAKMAK, R. Et Al. (2021) . "COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs?." Turkish Journal of Diabetes and Obesity , vol.5, no.3, pp.279-284.
@article{article, author={RAMAZAN ÇAKMAK Et Al. }, title={COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs?}, journal={Turkish Journal of Diabetes and Obesity}, year=2021, pages={279-284} }